{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:18:08Z","timestamp":1787728688767,"version":"build-2784847793"},"reference-count":245,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["24-45-10013"],"award-info":[{"award-number":["24-45-10013"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007595","name":"Belarusian Republican Foundation for Fundamental Research","doi-asserted-by":"crossref","award":["20240141"],"award-info":[{"award-number":["20240141"]}],"id":[{"id":"10.13039\/100007595","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neurodegenerative diseases, traumatic brain injuries, and strokes are accompanied by the development of secondary damage\u2014a long-term pathological cascade in which cerebrospinal fluid (CSF) plays a key role. Unlike primary damage, which is acute, secondary processes can progress over months and even years, creating a therapeutic window for neuroprotection. CSF acts not simply as a passive medium but as an active mediator of the spread of cytotoxic factors\u2014reactive oxygen species, glutamate, proinflammatory cytokines, pathological protein aggregates (A\u03b2, \u03b1-synuclein, tau, etc.), and exosomes\u2014which transport toxic molecules between brain regions. These processes are exacerbated by dysfunction of the blood-brain and blood\u2013cerebrospinal fluid barriers, leading to the accumulation of damaging agents in the CSF and accelerated neurodegeneration. This review examines the molecular mechanisms of secondary injury, the role of barrier systems in maintaining CSF homeostasis, and current therapeutic strategies aimed at modulating CSF composition. Particular attention is paid to innovative approaches to drug delivery to the central nervous system\u2014from bispecific antibodies and nanoparticles to invasive techniques such as immunoselective CSF aspiration and nanoporous implants. The potential of CSF as a source of diagnostic biomarkers and as a therapeutic target for personalized treatment of neurodegenerative conditions is highlighted.<\/jats:p>","DOI":"10.3390\/ijms262311541","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:19:51Z","timestamp":1764328791000},"page":"11541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modulating Cerebrospinal Fluid Composition in Neurodegenerative Processes: Modern Drug Delivery and Clearance Strategies"],"prefix":"10.3390","volume":"26","author":[{"given":"Elizaveta A.","family":"Dutysheva","sequence":"first","affiliation":[{"name":"Institute of Cytology, Russian Academy of Sciences, St. Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya V.","family":"Zaerko","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Grodno State Medical University, 230009 Grodno, Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikita A.","family":"Valko","sequence":"additional","affiliation":[{"name":"Scientific Laboratory, Grodno State Medical University, 230009 Grodno, Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina O.","family":"Antipina","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery, Grodno State Medical University, 230009 Grodno, Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey M.","family":"Zimatkin","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Grodno State Medical University, 230009 Grodno, Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Margulis","sequence":"additional","affiliation":[{"name":"Institute of Cytology, Russian Academy of Sciences, St. Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-7713","authenticated-orcid":false,"given":"Irina V.","family":"Guzhova","sequence":"additional","affiliation":[{"name":"Institute of Cytology, Russian Academy of Sciences, St. Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-6789","authenticated-orcid":false,"given":"Vladimir F.","family":"Lazarev","sequence":"additional","affiliation":[{"name":"Institute of Cytology, Russian Academy of Sciences, St. Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ioannidou, S., Tsolaki, M., Ginoudis, A., Tamvakis, A., Tsolaki, A., Makedou, K., and Lymperaki, E. (2025). Oxidative Stress Biomarkers as Preclinical Markers of Mild Cognitive Impairment: The Impact of Age and Sex. J. Pers. Med., 15.","DOI":"10.3390\/jpm15050171"},{"key":"ref_2","first-page":"S183","article-title":"Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson\u2019s Disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Park. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neurobiolaging.2024.06.001","article-title":"Cerebrospinal Fluid Biomarkers and Cognitive Trajectories in Patients with Alzheimer\u2019s Disease and a History of Traumatic Brain Injury","volume":"141","author":"Das","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jnc.15518","article-title":"Cerebrospinal Fluid Levels of L-Glutamate Signal Central Inflammatory Neurodegeneration in Multiple Sclerosis","volume":"159","author":"Nuzzo","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bagnato, S., and Boccagni, C. (2023). Cerebrospinal Fluid and Blood Biomarkers in Patients with Post-Traumatic Disorders of Consciousness: A Scoping Review. Brain Sci., 13.","DOI":"10.3390\/brainsci13020364"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","article-title":"Widespread Tau and Amyloid-Beta Pathology Many Years After a Single Traumatic Brain Injury in Humans","volume":"22","author":"Johnson","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The Spectrum of Disease in Chronic Traumatic Encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lazarev, V.F., Alhasan, B.A., Guzhova, I.V., and Margulis, B.A. (2025). \u201cProteinjury\u201d: A Universal Pathological Mechanism Mediated by Cerebrospinal Fluid in Neurodegeneration and Trauma. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1593122"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116001","DOI":"10.1016\/j.celrep.2025.116001","article-title":"TNF-\u03b1-NF-\u03baB Activation through Pathological \u03b1-Synuclein Disrupts the BBB and Exacerbates Axonopathy","volume":"44","author":"Jeon","year":"2025","journal-title":"Cell Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","article-title":"The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases","volume":"1788","author":"Weiss","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dutysheva, E.A., Mikeladze, M.A., Trestsova, M.A., Aksenov, N.D., Utepova, I.A., Mikhaylova, E.R., Suezov, R.V., Charushin, V.N., Chupakhin, O.N., and Guzhova, I.V. (2020). Pyrrolylquinoxaline-2-One Derivative as a Potent Therapeutic Factor for Brain Trauma Rehabilitation. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050414"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bbrc.2018.05.099","article-title":"GAPDH-Targeted Therapy\u2014A New Approach for Secondary Damage after Traumatic Brain Injury on Rats","volume":"501","author":"Lazarev","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dutysheva, E.A., Mikhaylova, E.R., Trestsova, M.A., Andreev, A.I., Apushkin, D.Y., Utepova, I.A., Serebrennikova, P.O., Akhremenko, E.A., Aksenov, N.D., and Bon\u2019, E.I. (2023). Combination of a Chaperone Synthesis Inducer and an Inhibitor of GAPDH Aggregation for Rehabilitation after Traumatic Brain Injury: A Pilot Study. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010007"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The Antibody Aducanumab Reduces A\u03b2 Plaques in Alzheimer\u2019s Disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-Targeting Therapies for Alzheimer Disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/13524585221076717","article-title":"Effect of Siponimod on Magnetic Resonance Imaging Measures of Neurodegeneration and Myelination in Secondary Progressive Multiple Sclerosis: Gray Matter Atrophy and Magnetization Transfer Ratio Analyses from the EXPAND Phase 3 Trial","volume":"28","author":"Arnold","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Munoz-Ballester, C., Mahmutovic, D., Rafiqzad, Y., Korot, A., and Robel, S. (2022). Mild Traumatic Brain Injury-Induced Disruption of the Blood-Brain Barrier Triggers an Atypical Neuronal Response. Front. Cell Neurosci., 16.","DOI":"10.3389\/fncel.2022.821885"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNO.0000000000001657","article-title":"Transsynaptic Ganglion Cell Degeneration in Adult Patients After Occipital Lobe Stroke","volume":"43","author":"Donaldson","year":"2023","journal-title":"J. Neuroophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1089\/ars.2010.3208","article-title":"Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory","volume":"14","author":"Massaad","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2174\/0929867321666131217153310","article-title":"Oxidative Stress in Traumatic Brain Injury","volume":"21","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02815160","article-title":"Mitochondrial Membrane Fluidity and Oxidative Damage to Mitochondrial DNA in Aged and AD Human Brain","volume":"31","author":"Mecocci","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0891-5849(99)00247-6","article-title":"Increased Lipoprotein Oxidation in Alzheimer\u2019s Disease","volume":"28","author":"Schippling","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1074\/jbc.273.19.11401","article-title":"Superoxide in Apoptosis","volume":"273","author":"Cai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2310\/6650.2001.33790","article-title":"Early Onset of Lipid Peroxidation after Human Traumatic Brain Injury: A Fatal Limitation for the Free Radical Scavenger Pharmacological Therapy?","volume":"49","author":"Cristofori","year":"2001","journal-title":"J. Investig. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brainresbull.2011.05.004","article-title":"The Role of Glutamate Receptors in Traumatic Brain Injury: Implications for Postsynaptic Density in Pathophysiology","volume":"85","author":"Luo","year":"2011","journal-title":"Brain Res. Bull."},{"key":"ref_26","first-page":"484","article-title":"Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms","volume":"15","author":"Somayaji","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/neu.1999.16.1215","article-title":"Chronic and Acute Compressive Spinal Cord Lesions in Dogs Due to Intervertebral Disc Herniation Are Associated with Elevation in Lumbar Cerebrospinal Fluid Glutamate Concentration","volume":"16","author":"Olby","year":"1999","journal-title":"J. Neurotrauma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00701-006-0771-z","article-title":"Multiparametric Analysis of Cerebral Substrates and Nitric Oxide Delivery in Cerebrospinal Fluid in Patients with Intracerebral Haemorrhage: Correlation with Hemodynamics and Outcome","volume":"148","author":"Chiang","year":"2006","journal-title":"Acta Neurochir."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-141899","article-title":"Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer\u2019s Disease Pathogenesis","volume":"46","author":"Ellis","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TA.0000000000000445","article-title":"Altering Leukocyte Recruitment Following Traumatic Brain Injury with Ghrelin Therapy","volume":"77","author":"Lee","year":"2014","journal-title":"J. Trauma. Acute Care Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TA.0000000000000468","article-title":"Clinical Evidence of Inflammation Driving Secondary Brain Injury: A Systematic Review","volume":"78","author":"Hinson","year":"2015","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The Association between Inflammatory Markers in Blood and Cerebrospinal Fluid: A Systematic Review and Meta-Analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jnc.15884","article-title":"Cerebrospinal Fluid, Brain, and Spinal Cord Levels of L-Aspartate Signal Excitatory Neurotransmission Abnormalities in Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Mouse Model","volume":"166","author":"Errico","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sabirov, D., Ogurcov, S., Shulman, I., Kabdesh, I., Garanina, E., Sufianov, A., Rizvanov, A., and Mukhamedshina, Y. (2023). Comparative Analysis of Cytokine Profiles in Cerebrospinal Fluid and Blood Serum in Patients with Acute and Subacute Spinal Cord Injury. Biomedicines, 11.","DOI":"10.1101\/2023.08.29.23294725"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0028-3886.16930","article-title":"Concomitant Upregulation of Nuclear Factor-KB Activity, Proinflammatory Cytokines and ICAM-1 in the Injured Brain after Cortical Contusion Trauma in a Rat Model","volume":"53","author":"Hang","year":"2005","journal-title":"Neurol. India"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1812","DOI":"10.1212\/WNL.0000000000207113","article-title":"Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia","volume":"100","author":"Gertje","year":"2023","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13054-016-1470-7","article-title":"Plasma Cytokines IL-6, IL-8, and IL-10 Are Associated with the Development of Acute Respiratory Distress Syndrome in Patients with Severe Traumatic Brain Injury","volume":"20","author":"Aisiku","year":"2016","journal-title":"Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114144","DOI":"10.1016\/j.expneurol.2022.114144","article-title":"FUS Aggregation Following Ischemic Stroke Favors Brain Astrocyte Activation through Inducing Excessive Autophagy","volume":"355","author":"Wu","year":"2022","journal-title":"Exp. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"D\u2019Anca, M., Fenoglio, C., Serpente, M., Arosio, B., Cesari, M., Scarpini, E.A., and Galimberti, D. (2019). Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00232"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Anagnostou, D., Sfakianaki, G., Melachroinou, K., Soutos, M., Constantinides, V., Vaikath, N., Tsantzali, I., Paraskevas, G.P., Agnaf, O.E., and Vekrellis, K. (2023). Assessment of Aggregated and Exosome-Associated \u03b1-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132192"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/awad260","article-title":"Aggregation and beyond: Alpha-Synuclein-Based Biomarkers in Synucleinopathies","volume":"147","author":"Chopra","year":"2024","journal-title":"Brain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-Associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease","volume":"287","author":"Saman","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16019","DOI":"10.1038\/npjamd.2016.19","article-title":"Extracellular Vesicle-Associated A\u03b2 Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer\u2019s Disease Models","volume":"2","author":"Eitan","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2537345","DOI":"10.1080\/07853890.2025.2537345","article-title":"Therapeutic Potential of Plant-Derived Exosome-like Nanoparticles for CNS Diseases: Advancements in Preparation and Characterization","volume":"57","author":"Liu","year":"2025","journal-title":"Ann. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.23627","article-title":"Myeloid Microvesicles Are a Marker and Therapeutic Target for Neuroinflammation","volume":"72","author":"Verderio","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Xue, S., Zhou, X., Yang, Z.H., Si, X.K., and Sun, X. (2023). Stroke-Induced Damage on the Blood-Brain Barrier. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1248970"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Canepa, E., and Fossati, S. (2021). Impact of Tau on Neurovascular Pathology in Alzheimer\u2019s Disease. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.573324"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, W., Man, X., Zhang, Y., Yao, G., and Chen, J. (2023). Medial Prefrontal Cortex Oxytocin Mitigates Epilepsy and Cognitive Impairments Induced by Traumatic Brain Injury through Reducing Neuroinflammation in Mice. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-32351-8"},{"key":"ref_49","first-page":"1147","article-title":"Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans","volume":"74","author":"Hay","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113257","DOI":"10.1016\/j.expneurol.2020.113257","article-title":"Brain Injury-Induced Dysfunction of the Blood Brain Barrier as a Risk for Dementia","volume":"328","author":"Abrahamson","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-Brain Barrier Breakdown Is an Early Biomarker of Human Cognitive Dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1177\/0271678X231180035","article-title":"Blood-Brain Barrier Breakdown Is Linked to Tau Pathology and Neuronal Injury in a Differential Manner According to Amyloid Deposition","volume":"43","author":"Moon","year":"2023","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3233\/JAD-231028","article-title":"A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer\u2019s Disease-Relevant Cognitive Changes in a Mouse Model","volume":"98","author":"Acharya","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijbiomac.2022.12.134","article-title":"The Impact of \u03b1-Synuclein Aggregates on Blood-Brain Barrier Integrity in the Presence of Neurovascular Unit Cells","volume":"229","author":"Hourfar","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cheemala, A., Kimble, A.L., Tyburski, J.D., Leclair, N.K., Zuberi, A.R., Murphy, M., Jellison, E.R., Reese, B., Hu, X., and Lutz, C.M. (2023). Loss of Endothelial TDP-43 Leads to Blood Brain Barrier Defects in Mouse Models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. bioRxiv.","DOI":"10.1101\/2023.12.13.571184"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e13258","DOI":"10.1111\/acel.13258","article-title":"Alzheimer\u2019s Amyloid \u03b2 Heterogeneous Species Differentially Affect Brain Endothelial Cell Viability, Blood-Brain Barrier Integrity, and Angiogenesis","volume":"19","author":"Ghiso","year":"2020","journal-title":"Aging Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.05.024","article-title":"Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction Are Present in the Tg-SwDI Mouse Model of Alzheimer\u2019s Disease","volume":"440","author":"Cuevas","year":"2020","journal-title":"Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-804279-3.00002-2","article-title":"The Cerebrospinal Fluid and Barriers\u2014Anatomic and Physiologic Considerations","volume":"146","author":"Tumani","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-60761-938-3_4","article-title":"The Blood-Cerebrospinal Fluid Barrier: Structure and Functional Significance","volume":"686","author":"Johanson","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1152\/physrev.00060.2021","article-title":"The Choroid Plexus: A Missing Link in Our Understanding of Brain Development and Function","volume":"103","author":"Saunders","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17425255.2018.1513493","article-title":"Impact of Transporters and Enzymes from Blood-Cerebrospinal Fluid Barrier and Brain Parenchyma on CNS Drug Uptake","volume":"14","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11095-022-03193-2","article-title":"Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery","volume":"39","author":"Huttunen","year":"2022","journal-title":"Pharm. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02688697.2021.1903390","article-title":"Choroid Plexus and CSF: An Updated Review","volume":"36","author":"Hutton","year":"2022","journal-title":"Br. J. Neurosurg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","article-title":"The Cerebrospinal Fluid Production Rate Is Reduced in Dementia of the Alzheimer\u2019s Type","volume":"57","author":"Silverberg","year":"2001","journal-title":"Neurology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.neurobiolaging.2008.08.017","article-title":"Abeta Accumulation in Choroid Plexus is Associated with Mitochondrial-Induced Apoptosis","volume":"31","author":"Vargas","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/alz.12970","article-title":"Pathogenesis of Alzheimer\u2019s Disease: Involvement of the Choroid Plexus","volume":"19","author":"Onyango","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","article-title":"Amyloid \u03b2 Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases","volume":"35","author":"Brkic","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ott, B.R., Jones, R.N., Daiello, L.A., de la Monte, S.M., Stopa, E.G., Johanson, C.E., Denby, C., and Grammas, P. (2018). Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer\u2019s Disease: Relationship to Inflammatory Cytokines and Chemokines. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00245"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Seeliger, T., Gingele, S., G\u00fczeloglu, Y.E., Heitmann, L., L\u00fcling, B., Kohle, F., Pre\u00dfler, H., Stascheit, F., Motte, J., and Fisse, A.L. (2024). Comparative Analysis of Albumin Quotient and Total CSF Protein in Immune-Mediated Neuropathies: A Multicenter Study on Diagnostic Implications. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1330484"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Szmydynger-Chodobska, J., Gandy, J.R., Varone, A., Shan, R., and Chodobski, A. (2013). Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079328"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12974-017-0909-3","article-title":"Choroid Plexus-Cerebrospinal Fluid Route for Monocyte-Derived Macrophages after Stroke","volume":"14","author":"Ge","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1403.008","article-title":"Intracerebroventricularly Administered Neurotrophins Attenuate Blood Cerebrospinal Fluid Barrier Breakdown and Brain Pathology Following Whole-Body Hyperthermia: An Experimental Study in the Rat Using Biochemical and Morphological Approaches","volume":"1122","author":"Sharma","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.2009.05329.x","article-title":"Cerebrolysin Reduces Blood-Cerebrospinal Fluid Barrier Permeability Change, Brain Pathology, and Functional Deficits Following Traumatic Brain Injury in the Rat","volume":"1199","author":"Sharma","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12987-023-00441-4","article-title":"The Choroid Plexus Acts as an Immune Cell Reservoir and Brain Entry Site in Experimental Autoimmune Encephalomyelitis","volume":"20","author":"Lazarevic","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Serra, R., and Simard, J.M. (2023). Adherens, Tight, and Gap Junctions in Ependymal Cells: A Systematic Review of Their Contribution to CSF-Brain Barrier. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1092205"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0012-1606(87)90119-9","article-title":"Spatial and Temporal Expression Pattern of N-Cadherin Cell Adhesion Molecules Correlated with Morphogenetic Processes of Chicken Embryos","volume":"120","author":"Hatta","year":"1987","journal-title":"Dev. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1073\/pnas.0911996107","article-title":"Establishment of a Neuroepithelial Barrier by Claudin5a Is Essential for Zebrafish Brain Ventricular Lumen Expansion","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1750-3639.2010.00432.x","article-title":"Neuroependymal Denudation Is in Progress in Full-Term Human Foetal Spina Bifida Aperta","volume":"21","author":"Sival","year":"2011","journal-title":"Brain Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.12779\/dnd.2018.17.1.32","article-title":"Hydrocephalus in a Patient with Alzheimer\u2019s Disease","volume":"17","author":"Kang","year":"2018","journal-title":"Dement. Neurocogn. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0025-7125(05)70108-5","article-title":"Differential Diagnosis of Parkinson\u2019s Disease","volume":"83","author":"Adler","year":"1999","journal-title":"Med. Clin. N. Am."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e17568","DOI":"10.1097\/MD.0000000000017568","article-title":"Incidence of Hydrocephalus in Traumatic Brain Injury: A Nationwide Population-Based Cohort Study","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-017-0438-4","article-title":"Hydrocephalus Due to Multiple Ependymal Malformations Is Caused by Mutations in the MPDZ Gene","volume":"5","author":"Marguet","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1089\/neu.2013.3110","article-title":"Traumatic Brain Injury-Induced Ependymal Ciliary Loss Decreases Cerebral Spinal Fluid Flow","volume":"31","author":"Xiong","year":"2014","journal-title":"J. Neurotrauma"},{"key":"ref_85","first-page":"295","article-title":"Immunodistribution of Amyloid Beta Protein (A\u03b2) and Advanced Glycation End-Product Receptors (RAGE) in Choroid Plexus and Ependyma of Resuscitated Patients","volume":"49","author":"Maslinska","year":"2011","journal-title":"Folia Neuropathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-7091-6549-2_2","article-title":"The Normal and Pathological Physiology of Brain Water","volume":"23","author":"Go","year":"1997","journal-title":"Adv. Tech. Stand. Neurosurg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00381-012-1910-x","article-title":"The Intracranial Arachnoid Mater: A Comprehensive Review of Its History, Anatomy, Imaging, and Pathology","volume":"29","author":"Adeeb","year":"2013","journal-title":"Childs Nerv. Syst."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF00334451","article-title":"Columnar Arrangement of Beta-Amyloid Protein Deposits in the Cerebral Cortex of Patients with Alzheimer\u2019s Disease","volume":"85","author":"Akiyama","year":"1993","journal-title":"Acta Neuropathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5114\/fn.2018.80860","article-title":"A Comparison of the Spatial Patterns of \u03b2-Amyloid (A\u03b2) Deposits in Five Neurodegenerative Disorders","volume":"56","author":"Armstrong","year":"2018","journal-title":"Folia Neuropathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A Paravascular Pathway Facilitates CSF Flow through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-11-107","article-title":"Evaluating Glymphatic Pathway Function Utilizing Clinically Relevant Intrathecal Infusion of CSF Tracer","volume":"11","author":"Yang","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2463\/mrms.rev.2020-0122","article-title":"The Glymphatic System: A Review of the Challenges in Visualizing Its Structure and Function with MR Imaging","volume":"21","author":"Naganawa","year":"2022","journal-title":"Magn. Reson. Med. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-022-00999-5","article-title":"Loss of Perivascular Aquaporin-4 Localization Impairs Glymphatic Exchange and Promotes Amyloid \u03b2 Plaque Formation in Mice","volume":"14","author":"Simon","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","article-title":"Glymphatic Failure as a Final Common Pathway to Dementia","volume":"370","author":"Nedergaard","year":"2020","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of Paravascular Clearance Pathways in the Aging Brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Fagan, A.M., and Perrin, R.J. (2012). Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease. Biomark. Med., 6.","DOI":"10.2217\/bmm.12.42"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.ajp.160.2.376","article-title":"Differentiation of Geriatric Major Depression from Alzheimer\u2019s Disease with CSF Tau Protein Phosphorylated at Threonine 231","volume":"160","author":"Buerger","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","article-title":"Developing Novel Blood-Based Biomarkers for Alzheimer\u2019s Disease","volume":"10","author":"Snyder","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s Disease: Current Status and Prospects for the Future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp.2006.107326","article-title":"CSF Neurofilament Proteins in the Differential Diagnosis of Dementia","volume":"78","author":"Jansen","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2009.09.008","article-title":"Biomarkers for Alzheimer\u2019s Disease and Other Forms of Dementia: Clinical Needs, Limitations and Future Aspects","volume":"45","author":"Winblad","year":"2010","journal-title":"Exp. Gerontol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS Clinical Diagnostic Criteria for Parkinson\u2019s Disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1007\/s12035-018-1426-9","article-title":"Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls","volume":"56","author":"Marques","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 Disaggregase Reverses Parkinson\u2019s-Linked \u03b1-Synuclein Amyloid Fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jalz.2016.09.008","article-title":"Recommendations for CSF AD Biomarkers in the Diagnostic Evaluation of Dementia","volume":"13","author":"Simonsen","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF Biomarkers and Clinical Progression of Parkinson Disease","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/mds.26754","article-title":"Longitudinal Changes in CSF Alpha-Synuclein Species Reflect Parkinson\u2019s Disease Progression","volume":"31","author":"Majbour","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-Synuclein RT-QuIC in the CSF of Patients with Alpha-Synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients with Dementia and\/or Parkinsonian Disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal Fluid Tau and Amyloid-\u03921-42 in Patients with Dementia","volume":"138","author":"Farahmand","year":"2015","journal-title":"Brain"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of Heterogeneity among Participants in the Parkinson\u2019s Progression Markers Initiative Cohort Using \u03b1-Synuclein Seed Amplification: A Cross-Sectional Study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.05.004","article-title":"Fluid Biomarkers in Multiple System Atrophy: A Review of the MSA Biomarker Initiative","volume":"80","author":"Laurens","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A Panel of Nine Cerebrospinal Fluid Biomarkers May Identify Patients with Atypical Parkinsonian Syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-014-0072-3","article-title":"Biomarkers in Biological Fluids for Dementia with Lewy Bodies","volume":"6","author":"Schade","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of Neurofilament Heavy Chain and Complement C3 as CSF Biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","article-title":"Protein Aggregation in Amyotrophic Lateral Sclerosis","volume":"125","author":"Blokhuis","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13643-018-0913-4","article-title":"CSF and Blood Biomarkers in Amyotrophic Lateral Sclerosis: Protocol for a Systematic Review and Meta-Analysis","volume":"7","author":"Agah","year":"2018","journal-title":"Syst. Rev."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid Biomarkers for Amyotrophic Lateral Sclerosis: A Review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","article-title":"Proteomic Profiling of Cerebrospinal Fluid Identifies Biomarkers for Amyotrophic Lateral Sclerosis","volume":"95","author":"Ranganathan","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jprot.2015.11.007","article-title":"Differential Proteomic and Genomic Profiling of Mouse Striatal Cell Model of Huntington\u2019s Disease and Control; Probable Implications to the Disease Biology","volume":"132","author":"Choudhury","year":"2016","journal-title":"J. Proteom."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/ene.12750","article-title":"Ubiquitin: A Potential Cerebrospinal Fluid Progression Marker in Huntington\u2019s Disease","volume":"22","author":"Simonsen","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000525701","article-title":"Case Report: Three Case Reports of Rapidly Progressive Dementias and Narrative Review","volume":"14","author":"Clavijo","year":"2022","journal-title":"Case Rep. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/ijms12096281","article-title":"Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease","volume":"12","author":"Zanusso","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive Human Prion Detection in Cerebrospinal Fluid by Real-Time Quaking-Induced Conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/clinchem\/hvad221","article-title":"CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges","volume":"70","author":"Jonaitis","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_126","first-page":"e12556","article-title":"Association of CSF Biomarkers with MRI Brain Changes in Alzheimer\u2019s Disease","volume":"16","author":"Seidu","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","article-title":"Comparison of CSF and Plasma NfL and PNfH for Alzheimer\u2019s Disease Diagnosis: A Memory Clinic Study","volume":"271","author":"Vrillon","year":"2024","journal-title":"J. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","article-title":"Cerebrospinal Fluid GFAP Is a Predictive Biomarker for Conversion to Dementia and Alzheimer\u2019s Disease-Associated Biomarkers Alterations among de Novo Parkinson\u2019s Disease Patients: A Prospective Cohort Study","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Wang, Z., Xiao, S., and Wan, M. (2025). Association of CSF Visinin-like Protein 1 Levels with Cerebral Glucose Metabolism among Older Adults. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0329386"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Voytyuk, I., Mueller, S.A., Herber, J., Snellinx, A., Moechars, D., van Loo, G., Lichtenthaler, S.F., and De Strooper, B. (2018). BACE2 Distribution in Major Brain Cell Types and Identification of Novel Substrates. Life Sci. Alliance, 1.","DOI":"10.26508\/lsa.201800026"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e200498","DOI":"10.1212\/NXI.0000000000200498","article-title":"Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease","volume":"12","author":"Farina","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00415-025-13384-7","article-title":"Effect of Aging on Biomarkers and Clinical Profile in Parkinson\u2019s Disease","volume":"272","author":"Bellomo","year":"2025","journal-title":"J. Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00415-025-13325-4","article-title":"CSF Phospho-Tau Levels at Parkinson\u2019s Disease Onset Predict the Risk for Development of Motor Complications","volume":"272","author":"Bissacco","year":"2025","journal-title":"J. Neurol."},{"key":"ref_134","first-page":"921","article-title":"Fluid Biomarkers in Atypical Parkinsonism: Current State and Future Perspectives","volume":"132","author":"Bougea","year":"2025","journal-title":"J. Neurol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Simonini, C., Zucchi, E., Martinelli, I., Gianferrari, G., Lunetta, C., Sorar\u00f9, G., Trojsi, F., Pepe, R., Piras, R., and Giacchino, M. (2025). Neurodegenerative and Neuroinflammatory Changes in SOD1-ALS Patients Receiving Tofersen. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-94984-1"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JIR.S298307","article-title":"Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study","volume":"14","author":"Pilely","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Bowser, R., An, J., Schwartz, K., Sucholeiki, R.L., and Sucholeiki, I. (2025). ALS Patients Exhibit Altered Levels of Total and Active MMP-9 and Several Other Biomarkers in Serum and CSF Compared to Healthy Controls and Other Neurologic Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188900"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"123479","DOI":"10.1016\/j.jns.2025.123479","article-title":"Exploring CSF Biomarkers in Amyotrophic Lateral Sclerosis: Highlighting the Significance of TDP-43","volume":"472","author":"Kuo","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e213914","DOI":"10.1212\/WNL.0000000000213914","article-title":"CSF A\u03b2, Tau, Axonal, Synaptic, Glial, Neural, and Inflammatory Biomarkers in Patients With Sporadic Amyotrophic Lateral Sclerosis","volume":"105","author":"Chen","year":"2025","journal-title":"Neurology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"102438","DOI":"10.1016\/j.nsa.2023.102438","article-title":"Cerebrospinal Fluid Ubiquitin as a Biomarker for Neurodegenerative Diseases: A Systematic Review","volume":"2","author":"Vardheim","year":"2023","journal-title":"Neurosci. Appl."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40035-024-00443-8","article-title":"Elevated Plasma and CSF Neurofilament Light Chain Concentrations Are Stabilized in Response to Mutant Huntingtin Lowering in the Brains of Huntington\u2019s Disease Mice","volume":"13","author":"Caron","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.49.2.593","article-title":"Detection of 14-3-3 Protein in the CSF of Genetic Creutzfeldt-Jakob Disease","volume":"49","author":"Rosenmann","year":"1997","journal-title":"Neurology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2004.12.003","article-title":"Dissociation between CSF Total Tau and Tau Protein Phosphorylated at Threonine 231 in Creutzfeldt-Jakob Disease","volume":"27","author":"Buerger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and Diagnostic Guidelines for Sporadic Creutzfeldt-Jakob Disease","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The Blood-Brain Barrier: Bottleneck in Brain Drug Development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/322639a0","article-title":"The Tight Junction Does Not Allow Lipid Molecules to Diffuse from One Epithelial Cell to the Next","volume":"322","author":"Gumbiner","year":"1986","journal-title":"Nature"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","article-title":"Blood-Brain Barrier Endogenous Transporters as Therapeutic Targets: A New Model for Small Molecule CNS Drug Discovery","volume":"19","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like Properties and the Causes of Poor Solubility and Poor Permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/jm990017w","article-title":"Designing Libraries with CNS Activity","volume":"42","author":"Ajay","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","article-title":"Small Molecular Drug Transfer across the Blood-Brain Barrier via Carrier-Mediated Transport Systems","volume":"2","author":"Tsuji","year":"2005","journal-title":"NeuroRx"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3187","article-title":"Coexistence of Passive and Carrier-Mediated Processes in Drug Transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Haqqani, A.S., B\u00e9langer, K., and Stanimirovic, D.B. (2024). Receptor-Mediated Transcytosis for Brain Delivery of Therapeutics: Receptor Classes and Criteria. Front. Drug Deliv., 4.","DOI":"10.3389\/fddev.2024.1360302"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","article-title":"Uptake of ANG1005, a Novel Paclitaxel Derivative, through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer","volume":"26","author":"Thomas","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A Peptide Derived from Melanotransferrin Delivers a Protein-Based Interleukin 1 Receptor Antagonist across the BBB and Ameliorates Neuropathic Pain in a Preclinical Model","volume":"39","author":"Thom","year":"2019","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/0271678X211035625","article-title":"Preclinical in Vivo Longitudinal Assessment of KG207-M as a Disease-Modifying Alzheimer\u2019s Disease Therapeutic","volume":"42","author":"Kang","year":"2022","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/acs.molpharmaceut.0c00495","article-title":"Effect of Cerebrospinal Fluid Circulation on Nose-to-Brain Direct Delivery and Distribution of Caffeine in Rats","volume":"17","author":"Inoue","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Tripathi, D., Pandey, P., Sharma, S., Rai, A.K., and Prabhu, M.B.H. (2024). Advances in Nanomaterials for Precision Drug Delivery: Insights into Pharmacokinetics and Toxicity. Bioimpacts, 15.","DOI":"10.34172\/bi.30573"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2174\/1568026615666150414145323","article-title":"Metal Based Frameworks for Drug Delivery Systems","volume":"15","author":"Popescu","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/bm700535p","article-title":"Surface Charge of Nanoparticles Determines Their Endocytic and Transcytotic Pathway in Polarized MDCK Cells","volume":"9","author":"Rozentur","year":"2008","journal-title":"Biomacromolecules"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/kfp087","article-title":"Mechanisms of Quantum Dot Nanoparticle Cellular Uptake","volume":"110","author":"Zhang","year":"2009","journal-title":"Toxicol. Sci."},{"key":"ref_163","first-page":"102453","article-title":"Attenuation of Blood-Brain Barrier Dysfunction by Functionalized Gold Nanoparticles Against Amyloid-\u0392 Peptide in an Alzheimer\u2019s Disease-on-A-Chip Model","volume":"35","author":"Arellano","year":"2025","journal-title":"Mater. Today Fam. J."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2023.01.054","article-title":"Glymphatic-Assisted Perivascular Brain Delivery of Intrathecal Small Gold Nanoparticles","volume":"355","author":"Lilius","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/acs.analchem.7b03468","article-title":"Light-Up Nonthiolated Aptasensor for Low-Mass, Soluble Amyloid-\u039240 Oligomers at High Salt Concentrations","volume":"90","author":"Deng","year":"2018","journal-title":"Anal. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/17425247.2018.1504018","article-title":"Solid Lipid Nanocarriers in Drug Delivery: Characterization and Design","volume":"15","author":"Mu","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/anie.201804067","article-title":"Cubosomes: The Next Generation of Smart Lipid Nanoparticles?","volume":"58","author":"Barriga","year":"2019","journal-title":"Angew. Chem.-Int. Ed."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The Role of Lipid Components in Lipid Nanoparticles for Vaccines and Gene Therapy","volume":"188","author":"Kulkarni","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1039\/c2fo00005a","article-title":"Lipid Polymorphism in Lyotropic Liquid Crystals for Triggered Release of Bioactives","volume":"3","author":"Garti","year":"2012","journal-title":"Food Funct."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acsnano.8b07961","article-title":"Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine","volume":"13","author":"Zhai","year":"2019","journal-title":"ACS Nano"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcis.2020.12.060","article-title":"Synthetic Ionizable Aminolipids Induce a PH Dependent Inverse Hexagonal to Bicontinuous Cubic Lyotropic Liquid Crystalline Phase Transition in Monoolein Nanoparticles","volume":"589","author":"Rajesh","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cis.2008.07.007","article-title":"Characterization and Potential Applications of Nanostructured Aqueous Dispersions","volume":"147\u2013148","author":"Yaghmur","year":"2009","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery. I. Production, Characterization and Sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Release"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery\u2014Drug Release and Release Mechanism","volume":"45","author":"Schwarz","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(99)00223-0","article-title":"Vitamin A-Loaded Solid Lipid Nanoparticles for Topical Use: Drug Release Properties","volume":"66","author":"Jenning","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.sjbs.2020.04.045","article-title":"The Potential Role of Pomegranate and Its Nano-Formulations on Cerebral Neurons in Aluminum Chloride Induced Alzheimer Rat Model","volume":"27","author":"Almuhayawi","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"146325","DOI":"10.1016\/j.brainres.2019.146325","article-title":"Neuroprotective Effects of Curcumin Lipid-Core Nanocapsules in a Model Alzheimer\u2019s Disease Induced by \u03b2-Amyloid 1-42 Peptide in Aged Female Mice","volume":"1721","author":"Giacomeli","year":"2019","journal-title":"Brain Res."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Dara, T., Vatanara, A., Sharifzadeh, M., Khani, S., Vakilinezhad, M.A., Vakhshiteh, F., Nabi Meybodi, M., Sadegh Malvajerd, S., Hassani, S., and Mosaddegh, M.H. (2019). Improvement of Memory Deficits in the Rat Model of Alzheimer\u2019s Disease by Erythropoietin-Loaded Solid Lipid Nanoparticles. Neurobiol. Learn. Mem., 166.","DOI":"10.1016\/j.nlm.2019.107082"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.injury.2008.03.010","article-title":"Erythropoietin Improves Oxidative Stress Following Spinal Cord Trauma in Rats","volume":"39","author":"Yazihan","year":"2008","journal-title":"Injury"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.14715\/cmb\/2023.69.10.35","article-title":"Erythropoietin Relieves Neuronal Apoptosis in Epilepsy Rats via TGF-\u03b2\/Smad Signaling Pathway","volume":"69","author":"Pan","year":"2023","journal-title":"Cell Mol. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/WNR.0000000000001957","article-title":"Recombinant Human Erythropoietin Protects against Immature Brain Damage Induced by Hypoxic\/Ischemia Insult","volume":"34","author":"Sun","year":"2023","journal-title":"Neuroreport"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2309225","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle-Mediated Delivery of Anti-PU.1 SiRNA via Localized Intracisternal Administration Reduces Neuroinflammation","volume":"36","author":"Ralvenius","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jconrel.2024.07.044","article-title":"Biofluid Specific Protein Coronas Affect Lipid Nanoparticle Behavior In Vitro","volume":"373","author":"Sork","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Sung, Y.K., and Kim, S.W. (2020). Recent Advances in Polymeric Drug Delivery Systems. Biomater. Res., 24.","DOI":"10.1186\/s40824-020-00190-7"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"104501","DOI":"10.1016\/j.reactfunctpolym.2020.104501","article-title":"Recent Advances in Natural Polymer-Based Drug Delivery Systems","volume":"148","author":"Tong","year":"2020","journal-title":"React. Funct. Polym."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"153324","DOI":"10.1016\/j.phymed.2020.153324","article-title":"Thymoquinone Administration Ameliorates Alzheimer\u2019s Disease-like Phenotype by Promoting Cell Survival in the Hippocampus of Amyloid Beta1\u201342 Infused Rat Model","volume":"79","author":"Elibol","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"102214","DOI":"10.1016\/j.jddst.2020.102214","article-title":"Brain Targeted Polysorbate-80 Coated PLGA Thymoquinone Nanoparticles for the Treatment of Alzheimer\u2019s Disease, with Biomechanistic Insights","volume":"61","author":"Yusuf","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., and Kumar, D.S. (2012). Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer\u2019s Disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032616"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer\u2019s Disease Model via Canonical Wnt\/\u03b2-Catenin Pathway","volume":"8","author":"Tiwari","year":"2014","journal-title":"ACS Nano"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2311128","DOI":"10.1002\/smll.202311128","article-title":"Platelet Membrane-Coated Curcumin-PLGA Nanoparticles Promote Astrocyte-Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.colsurfb.2017.10.062","article-title":"Solid Lipid Nanoparticles for Delivery of Andrographolide across the Blood-Brain Barrier: In Vitro and in Vivo Evaluation","volume":"161","author":"Graverini","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2017.06.018","article-title":"Andrographolide-Loaded Nanoparticles for Brain Delivery: Formulation, Characterisation and In Vitro Permeability Using HCMEC\/D3 Cell Line","volume":"119","author":"Guccione","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","article-title":"Design of PLGA-Functionalized Quercetin Nanoparticles for Potential Use in Alzheimer\u2019s Disease","volume":"148","author":"Sun","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_194","first-page":"1719","article-title":"Phytol-Loaded PLGA Nanoparticle as a Modulator of Alzheimer\u2019s Toxic A\u03b2 Peptide Aggregation and Fibrillation Associated with Impaired Neuronal Cell Function","volume":"46","author":"Sathya","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10610270601012776","article-title":"Solubilization and Release Properties of Dendrimers. Evaluation as Prospective Drug Delivery Systems","volume":"18","author":"Santo","year":"2006","journal-title":"Supramol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/2211738504666160213000307","article-title":"Dendrimer-Drug Conjugates in Drug Delivery and Targeting","volume":"3","author":"Singh","year":"2016","journal-title":"Pharm. Nanotechnol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"McCarthy, J.M., Franke, M., Resenberger, U.K., Waldron, S., Simpson, J.C., Tatzelt, J., Appelhans, D., and Rogers, M.S. (2013). Anti-Prion Drug MPPIg5 Inhibits PrPC Conversion to PrPSc. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055282"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Zhong, G., Long, H., Zhou, T., Liu, Y., Zhao, J., Han, J., Yang, X., Yu, Y., Chen, F., and Shi, S. (2022). Blood-Brain Barrier Permeable Nanoparticles for Alzheimer\u2019s Disease Treatment by Selective Mitophagy of Microglia. Biomaterials, 288.","DOI":"10.1016\/j.biomaterials.2022.121690"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Evren, G., Er, E., Yalcinkaya, E.E., Horzum, N., and Odaci, D. (2023). Electrospun Nanofibers Including Organic\/Inorganic Nanohybrids: Polystyrene- and Clay-Based Architectures in Immunosensor Preparation for Serum Amyloid A. Biosensors, 13.","DOI":"10.3390\/bios13070673"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2015.02.066","article-title":"Carbosilane Dendrimers Inhibit \u03b1-Synuclein Fibrillation and Prevent Cells from Rotenone-Induced Damage","volume":"484","author":"Milowska","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1039\/c0cs00097c","article-title":"Design of Biocompatible Dendrimers for Cancer Diagnosis and Therapy: Current Status and Future Perspectives","volume":"40","author":"Cheng","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.apsb.2022.07.003","article-title":"Polymeric Nanocarriers for Nose-to-Brain Drug Delivery in Neurodegenerative Diseases and Neurodevelopmental Disorders","volume":"13","author":"Awad","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/09205063.2019.1680929","article-title":"Long Term Multiple Sclerosis Drug Delivery Using Dendritic Polyglycerol Flower-like Microspheres","volume":"31","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Doran, S.J., and Sawyer, R.P. (2024). Risk Factors in Developing Amyloid Related Imaging Abnormalities (ARIA) and Clinical Implications. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1326784"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Boado, R.J. (2022). IgG Fusion Proteins for Brain Delivery of Biologics via Blood\u2013Brain Barrier Receptor-Mediated Transport. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071476"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e00510","DOI":"10.1016\/j.neurot.2024.e00510","article-title":"A Brain-Penetrant Bispecific Antibody Lowers Oligomeric Alpha-Synuclein and Activates Microglia in a Mouse Model of Alpha-Synuclein Pathology","volume":"22","author":"Sehlin","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-018-0849-8","article-title":"Neurocognitive and Somatic Stabilization in Pediatric Patients with Severe Mucopolysaccharidosis Type I after 52 Weeks of Intravenous Brain-Penetrating Insulin Receptor Antibody-Iduronidase Fusion Protein (Valanafusp Alpha): An Open Label Phase 1-2 Trial","volume":"13","author":"Giugliani","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/bc060349x","article-title":"Fusion Antibody for Alzheimer\u2019s Disease with Bidirectional Transport Across the Blood-Brain Barrier and Abeta Fibril Disaggregation","volume":"18","author":"Boado","year":"2007","journal-title":"Bioconjug Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.174.6.1483","article-title":"A Tumor Necrosis Factor (TNF) Receptor-IgG Heavy Chain Chimeric Protein as a Bivalent Antagonist of TNF Activity","volume":"174","author":"Peppel","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(97)00981-5","article-title":"Neuroprotective Effects of TNF Binding Protein in Focal Cerebral Ischemia","volume":"778","author":"Nawashiro","year":"1997","journal-title":"Brain Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-5728(98)00273-2","article-title":"Early Neuronal Expression of Tumor Necrosis Factor-\u03b1 after Experimental Brain Injury Contributes to Neurological Impairment","volume":"95","author":"Knoblach","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejpain.2008.08.001","article-title":"Effects of Etanercept and Minocycline in a Rat Model of Spinal Cord Injury","volume":"13","author":"Marchand","year":"2009","journal-title":"Eur. J. Pain"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/156720507781788873","article-title":"TNF-\u03b1 Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets","volume":"4","author":"Tweedie","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","article-title":"Depression, Comorbidities and the TNF-\u03b1 System","volume":"23","author":"Himmerich","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Ort\u00ed-Casa\u00f1, N., Boerema, A.S., K\u00f6pke, K., Ebskamp, A., Keijser, J., Zhang, Y., Chen, T., Dolga, A.M., Broersen, K., and Fischer, R. (2023). The TNFR1 Antagonist Atrosimab Reduces Neuronal Loss, Glial Activation and Memory Deficits in an Acute Mouse Model of Neurodegeneration. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-36846-2"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic Engineering of a Lysosomal Enzyme Fusion Protein for Targeted Delivery across the Human Blood-Brain Barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Lu, J.Z., Boado, R.J., Hui, E.K.W., Zhou, Q.H., and Pardridge, W.M. (2011). Expression in CHO Cells and Pharmacokinetics and Brain Uptake in the Rhesus Monkey of an IgG-Iduronate-2-Sulfatase Fusion Protein. Biotechnol. Bioeng., 108.","DOI":"10.1002\/bit.23118"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1096\/fj.201500078","article-title":"Brain Penetration, Target Engagement, and Disposition of the Blood-Brain Barrier-Crossing Bispecific Antibody Antagonist of Metabotropic Glutamate Receptor Type 1","volume":"30","author":"Webster","year":"2016","journal-title":"FASEB J."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Boado, R.J., Hui, E.K.W., Lu, J.Z., Zhou, Q.H., and Pardridge, W.M. (2010). Selective Targeting of a TNFR Decoy Receptor Pharmaceutical to the Primate Brain as a Receptor-Specific IgG Fusion Protein. J. Biotechnol., 146.","DOI":"10.1016\/j.jbiotec.2010.01.011"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/jpet.109.165092","article-title":"Drug Targeting of Erythropoietin across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse","volume":"333","author":"Boado","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bit.21764","article-title":"GDNF Fusion Protein for Targeted-Drug Delivery across the Human Blood-Brain Barrier","volume":"100","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/bit.21369","article-title":"Genetic Engineering, Expression, and Activity of a Fusion Protein of a Human Neurotrophin and a Molecular Trojan Horse for Delivery across the Human Blood-Brain Barrier","volume":"97","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Pornnoppadol, G., Bond, L.G., Lucas, M.J., Zupancic, J.M., Kuo, Y.H., Zhang, B., Greineder, C.F., and Tessier, P.M. (2023). Bispecific Antibody Shuttles Targeting CD98hc Mediate Efficient and Long-Lived Brain Delivery of IgGs. Cell Chem. Biol., 31.","DOI":"10.1101\/2023.04.29.538811"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Menendez-Gonzalez, M. (2024). Intrathecal Immunoselective Nanopheresis for Alzheimer\u2019s Disease: What and How? Why and When?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910632"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Teleanu, R.I., Preda, M.D., Niculescu, A.G., Vlad\u00e2cenco, O., Radu, C.I., Grumezescu, A.M., and Teleanu, D.M. (2022). Current Strategies to Enhance Delivery of Drugs across the Blood\u2013Brain Barrier. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050987"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bjae.2019.11.002","article-title":"Complications Associated with Intrathecal Drug Delivery Systems","volume":"20","author":"Delhaas","year":"2020","journal-title":"BJA Educ."},{"key":"ref_227","first-page":"1575","article-title":"Neurofilament Medium Polypeptide (NFM) Protein Concentration Is Increased in CSF and Serum Samples from Patients with Brain Injury","volume":"53","author":"Childs","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Manuel, M.G., Tamba, B.I., Leclere, M., Mabrouk, M., Schreiner, T.G., Ciobanu, R., and Cristina, T.Z. (2023). Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030768"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.desal.2004.01.007","article-title":"A Comprehensive Review of Nanofiltration Membranes:Treatment, Pretreatment, Modelling, and Atomic Force Microscopy","volume":"170","author":"Hilal","year":"2004","journal-title":"Desalination"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Shukla, A.K., Alam, J., and Alhoshan, M. (2022). Recent Advancements in Polyphenylsulfone Membrane Modification Methods for Separation Applications. Membranes, 12.","DOI":"10.3390\/membranes12020247"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.desal.2013.06.016","article-title":"A Review on Membrane Fabrication: Structure, Properties and Performance Relationship","volume":"326","author":"Lalia","year":"2013","journal-title":"Desalination"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2147\/IJN.S402954","article-title":"Potential Biomedical Limitations of Graphene Nanomaterials","volume":"18","author":"Ban","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"42017","DOI":"10.1038\/s41598-025-26181-z","article-title":"Modulation of Experimental Alzheimer\u2019s Disease in Rats through Donepezil-Loaded CSF Implant","volume":"15","author":"Osama","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_234","first-page":"287","article-title":"Health Technology Assessment of Pathogen Reduction Technologies Applied to Plasma for Clinical Use","volume":"14","author":"Cicchetti","year":"2016","journal-title":"Blood Transfus."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Coto-Vilcapoma, M.A., Castilla-Silgado, J., Fern\u00e1ndez-Garc\u00eda, B., Pinto-Hern\u00e1ndez, P., Cipriani, R., Capetillo-Zarate, E., Men\u00e9ndez-Gonz\u00e1lez, M., \u00c1lvarez-Vega, M., and Tom\u00e1s-Zapico, C. (2022). New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169256"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Peydayesh, M. (2022). Nanofiltration Membranes: Recent Advances and Environmental Applications. Membranes, 12.","DOI":"10.3390\/books978-3-0365-4335-2"},{"key":"ref_237","first-page":"e1022","article-title":"Implantable Systems for Continuous Liquorpheresis and CSF Replacement","volume":"9","year":"2017","journal-title":"Cureus"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/17434440.2023.2181695","article-title":"Mechanical Filtration of the Cerebrospinal Fluid: Procedures, Systems, and Applications","volume":"20","year":"2023","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02191142","article-title":"Liquorpheresis Eliminates Blocking Factors from Cerebrospinal Fluid in Polyradiculoneuritis (Guillain-Barr\u00e9 Syndrome)","volume":"241","author":"Wollinsky","year":"1991","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Proctor, M.R., Black, P.M., Vogel, T.W., and Bruce, J.N. (2005). Local Delivery Methods into the CNS. Minimally Invasive Neurosurgery, Humana Press.","DOI":"10.1385\/1592598994"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/j.neuroimage.2010.01.023","article-title":"Image-Guided Convection-Enhanced Delivery of GDNF Protein into Monkey Putamen","volume":"54","author":"Gimenez","year":"2011","journal-title":"Neuroimage"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1088\/0034-4885\/64\/7\/202","article-title":"Diffusion and Related Transportmechanisms in Brain Tissue","volume":"64","author":"Nicholson","year":"2001","journal-title":"Rep. Progress Phys."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2019.10.FOCUS19679","article-title":"Deformational Changes after Convection-Enhanced Delivery in the Pediatric Brainstem","volume":"48","author":"Bander","year":"2020","journal-title":"Neurosurg. Focus."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/neuonc\/noaa101","article-title":"A Combined Approach of Convection-Enhanced Delivery of Peptide Nanofiber Reservoir to Prolong Local DM1 Retention for Diffuse Intrinsic Pontine Glioma Treatment","volume":"22","author":"Bellat","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Mikeladze, M.A., Dutysheva, E.A., Kartsev, V.G., Margulis, B.A., Guzhova, I.V., and Lazarev, V.F. (2021). Disruption of the Complex between GAPDH and Hsp70 Sensitizes C6 Glioblastoma Cells to Hypoxic Stress. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041520"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:25:09Z","timestamp":1764480309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":245,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311541"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311541","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}